Hui Kang
- Co-authors
- Li GaoGuang‐Biao ZhouFengxiang ZhangXiangqin WengMing YanZhixiang ShenZhenyi WangChen Zhu
- Topics
- Cancer Cells and Metastasis (4 papers)Microfluidic and Bio-sensing Technologies (2 papers)3D Printing in Biomedical Research (2 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Hui Kang
9 papers receiving 360 citations
Peers
Comparison fields: 5 of 68
- Molecular Biology 301
- Biomedical Engineering 59
- Pharmacology 47
- Cancer Research 46
- Hematology 36
Countries citing papers authored by Hui Kang
This map shows the geographic impact of Hui Kang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Kang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Kang more than expected).
Fields of papers citing papers by Hui Kang
This network shows the impact of papers produced by Hui Kang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Kang. The network helps show where Hui Kang may publish in the future.
Co-authorship network of co-authors of Hui Kang
This figure shows the co-authorship network connecting the top 25 collaborators of Hui Kang. A scholar is included among the top collaborators of Hui Kang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui Kang. Hui Kang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 3 | |
| 5 | 2 | |
| 6 | 7 | |
| 7 | 4 | |
| 8 | 97 | |
| 9 | 5 | |
| 10 | A bispecific aptamer targeting both VEGF and Angiopoietin-2 for treating retinal diseases | 1 |
| 11 | 61 | |
| 12 | 183 |
About Hui Kang
Hui Kang is a scholar working on Genetics, Oncology and Cancer Research, having authored 12 papers that have together received 363 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (4 papers), Microfluidic and Bio-sensing Technologies (2 papers) and 3D Printing in Biomedical Research (2 papers). The work is most often cited by research in Pharmacology (47 citations), Molecular Biology (301 citations) and Hematology (36 citations). Hui Kang has collaborated with scholars based in China and United States. Frequent co-authors include Li Gao, Guang‐Biao Zhou, Fengxiang Zhang, Xiangqin Weng, Ming Yan, Zhixiang Shen, Zhenyi Wang, Chen Zhu, Ping Liu and Sai‐Juan Chen. Their work appears in journals such as Nature Communications, Blood and Analytical Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.